Hyundai Bioland현대바이오랜드
052260 · KOSDAQ · ₩052260 · 현대바이오랜드
- Market cap
- ₩128B
- Enterprise value
- ₩125B
- P/E
- 9.6×
- P/B
- 0.9×
- Dividend yield
- 0.0%
- ROE
- 9.2%
- Net margin
- 9.5%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−31.7% from the high
₩3,125Today: ₩4,120 – ₩4,340₩6,240
Returns
- 1W−4.1%
- 1M−2.4%
- 3M+32.1%
- 6M−5.1%
- YTD−0.8%
- 1Y−5.3%
- Volume today
- 124,690
- 0.1× the 20-day average
- Traded today
- ₩526M
- Listed shares
- 30,000,000
- EPS (12 months)
- ₩445
- Earnings yield 10.4%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumFlat6.9% over the last month; the price is below its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Hyundai Bioland stock overview
Hyundai Bioland (현대바이오랜드, KRX: 052260) is listed on KOSDAQ, in the Chemicals sector. Hyundai Bioland is a South Korean company that develops natural bio-based materials and operates across cosmetics, health functional foods, pharmaceutical raw materials (APIs), medical devices, and brand distribution. Its shares closed at ₩4,260 on Oct 28, 2026, up 0.12% on the day, giving it a market value of ₩128B.
Key facts
- Market cap
- ₩128B
- Sector
- Chemicals
- Latest price change
- +0.12%
- As of
- Oct 28, 2026
- Main business
- Hyundai Bioland is a South Korean company that develops natural bio-based materials and operates across cosmetics, health functional foods, pharmaceutical raw materials (APIs), medical devices, and brand distribution.
Quick answers about Hyundai Bioland
- What does Hyundai Bioland do?
- Hyundai Bioland is a South Korean company that develops natural bio-based materials and operates across cosmetics, health functional foods, pharmaceutical raw materials (APIs), medical devices, and brand distribution. Its core cosmetics business supplies natural ingredients such as hyaluronic acid and Machilus extract to global beauty companies, and it exports to markets including Europe, the United States, and over 30 countries; its brand business exclusively distributes Nestlé Health Science brands such as Solgar in South Korea.
- What is the market cap of Hyundai Bioland?
- The market capitalisation of Hyundai Bioland was ₩128B at the close on Oct 28, 2026.
- Who are the largest shareholders of Hyundai Bioland?
- According to the latest official filings, the largest reported holders are EMERGING MARKETS CORE EQUITY 2 PORTFOLIO (0.36%, as of Jul 31, 2026); Dimensional Emerging Markets Core Equity 2 ETF (0.10%, as of Jul 31, 2026); State Street(R) SPDR(R) S&P(R) International Small Cap ETF (0.09%, as of Jun 30, 2026).
- When is the next earnings report from Hyundai Bioland?
- Korean companies rarely announce results dates in advance. Based on when Hyundai Bioland filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own Hyundai Bioland?
- Yes. The National Pension Service held 0.00% of Hyundai Bioland shares as of Dec 31, 2021.
Company profile
Hyundai Bioland is a South Korean company that develops natural bio-based materials and operates across cosmetics, health functional foods, pharmaceutical raw materials (APIs), medical devices, and brand distribution. Its core cosmetics business supplies natural ingredients such as hyaluronic acid and Machilus extract to global beauty companies, and it exports to markets including Europe, the United States, and over 30 countries; its brand business exclusively distributes Nestlé Health Science brands such as Solgar in South Korea.
Written by AI from the company's latest annual report.
- Korean name
- 현대바이오랜드
- Sector
- Chemicals
- Themes
- K-beauty
- Business group
- Hyundai Department Store
- CEO
- 이희준
- Founded
- Sep 1995
- Listed
- May 2001
- Listed shares
- 30,000,000
- Fiscal year ends
- Month 12
- Website
- www.hyundaibioland.co.kr
Similar companies
- LG Chem051910 · ₩17T₩236,000+3.28%
- Hanwha Solutions009830 · ₩6T₩26,700+3.29%
- Hanwha000880 · ₩5T₩94,000+1.40%
- SKC011790 · ₩4.1T₩82,900−0.36%
- KCC002380 · ₩3.4T₩397,000+5.31%
- Kumho Petro Chemical011780 · ₩2.7T₩106,800+0.75%
- Soulbrain357780 · ₩2.5T₩318,000+3.58%
- Hansol Chemical014680 · ₩2.4T₩219,500+7.60%
Recent filings
See all- Advance Notice of Earnings Results DisclosureOct 28, 2026
- Disclosure on Large Business Group Status [Quarterly Disclosure (For Individual Company)]Aug 28, 2026
- Investor relations (IR) eventAug 26, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Matters Concerning Payment Amounts by Payment Method and Payment Period, and Dispute Mediation BodiesAug 14, 2026
Titles in Korean until English translations are added.
Also known as: Hyundai Bioland / 현대바이오랜드 / 052260 / KRX:052260
Source: KRX statistical information